The latest quarterly R&D expense is $2.09 Million with a QoQ Growth of -51.10%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q4 FY2026 (2026-05-31).
Reported quarterly R&D expense; no daily interpolation. Q4 FY2026 (2026-05-31): $2.09M.
$2.09M
$2.09 Million
Q4 FY2026 · 2026-05-31
-51.10%
vs. $4.28M prior quarter
17
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q4 FY2026Period end 2026-05-31 | $2.09M | -51.10% | +15.51% |
| Q3 FY2026Period end 2026-02-28 | $4.28M | +131.68% | +1299.29% |
| Q2 FY2026Period end 2025-11-30 | $1.85M | -6.62% | +506.72% |
| Q1 FY2026Period end 2025-08-31 | $1.98M | +9.17% | +799.80% |
| Q4 FY2025Period end 2025-05-31 | $1.81M | +492.43% | +908.95% |
| Q3 FY2025Period end 2025-02-28 | $306.06K | +0.46% | +53.96% |
| Q2 FY2025Period end 2024-11-30 | $304.66K | +38.49% | N/A |
| Q1 FY2025Period end 2024-08-31 | $219.99K | +22.41% | N/A |
| Q4 FY2024Period end 2024-05-31 | $179.71K | -9.60% | N/A |
| Q3 FY2024Period end 2024-02-29 | $198.79K | N/A | N/A |
| Q2 FY2024Period end 2023-12-31 | $165.24K | +54.81% | +39.28% |
| Q1 FY2024Period end 2023-09-30 | $106.73K | -20.96% | -25.59% |
| Q4 FY2023Period end 2023-06-30 | $135.04K | +32.34% | N/A |
| Q3 FY2023Period end 2023-03-31 | $102.04K | -13.99% | N/A |
| Q2 FY2023Period end 2022-12-31 | $118.63K | -17.29% | N/A |
| Q1 FY2023Period end 2022-09-30 | $143.44K | N/A | N/A |
| Q4 FY2022Period end 2022-06-30 | $0 | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
